immunomodulation | Media Room | PressRelease.com

Tagged immunomodulation

Longevity Biotech Initiates Clinical Neuroinflammation Biomarker Study at the Department of Veterans Affairs to Investigate Immune Related Aspects of Parkinson's Disease With Continued Support From the Michael J. Fox Foundation

Press Release Jul 16, 2018

Longevity Biotech Initiates Clinical Neuroinflammation Biomarker Study at the Department of Veterans Affairs to Investigate Immune Related Aspects of Parkinson's Disease With Continued Support From the Michael J. Fox Foundation

Study aims to identify novel blood-based inflammatory markers that can be used to both identify and stratify Parkinson's disease patients Read More

Longevity Biotech Awarded $225K Phase I SBIR Contract From NHLBI/NIH to Develop 5A apoA-I Mimetic Peptide for Treatment of Severe Asthma

Press Release Jan 2, 2018

Longevity Biotech Awarded $225K Phase I SBIR Contract From NHLBI/NIH to Develop 5A apoA-I Mimetic Peptide for Treatment of Severe Asthma

Broadens immunomodulatory peptide portfolio while also expanding route of administration capabilities Read More

Longevity Biotech Awarded Grant From National Multiple Sclerosis Society to Evaluate LBT-3627 as a Novel Drug Candidate for Multiple Sclerosis

Press Release Oct 27, 2017

Longevity Biotech Awarded Grant From National Multiple Sclerosis Society to Evaluate LBT-3627 as a Novel Drug Candidate for Multiple Sclerosis

Launches preclinical development effort of LBT-3627 as a neuroprotective/repair treatment for Multiple Sclerosis Read More

First
Prev

1

Next
Last